Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Sep;98(1):41-3.
doi: 10.1111/j.1476-5381.1989.tb16860.x.

Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia

Affiliations

Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia

R L Follenfant et al. Br J Pharmacol. 1989 Sep.

Abstract

The cytokine interleukin-1 beta (IL-1 beta) is a potent hyperalgesic agent in the rat whereas IL-1 alpha is relatively inactive (Ferreira et al., 1988). IL-1 beta induced a dose-dependent increase in the sensitivity of rat paws to mechanical stimulation following intra-plantar injection but this effect was not reduced by indomethacin (1.0 mg kg-1, p.o.), at a dose known to inhibit completely prostaglandin synthesis in the rat (Salmon et al., 1983). Prostaglandin (PG)E2 enhanced sensitivity to both mechanical pressure and increased temperature but IL-1 beta enhanced only sensitivity to pressure. These observations indicate that IL-1 beta sensitized pressure-sensitive but not temperature-sensitive sensory neurones, through a prostaglandin-independent mechanism. Hyperalgesia induced by IL-1 beta but not PGE2, was inhibited by the neuropeptide melanocyte-stimulating hormone (alpha MSH) and its analogue [Nle4, D-Phe7] alpha MSH which are known to antagonize IL-1 responses in other systems (Holdeman & Lipton, 1985; Cannon et al., 1986). IL-1 beta-induced hyperalgesia was also reduced by the putative IL-1 beta antagonist Lys-D-Pro-Thr (Ferreira et al., 1988) but alpha MSH and its analogue were 10-50 times more potent.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1972 Jul 1;136(1):128-42 - PubMed
    1. J Physiol. 1980 Apr;301:69-78 - PubMed
    1. Peptides. 1981 Winter;2(4):419-23 - PubMed
    1. J Pharm Pharmacol. 1983 Dec;35(12):808-13 - PubMed
    1. Nature. 1988 Aug 25;334(6184):698-700 - PubMed